{"id":"W2807791746","doi":"10.1016/s0140-6736(18)31115-2","title":"Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trial","year":2018,"lang":"en","type":"article","venue":"The Lancet","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":397,"is_retracted":false,"has_abstract":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Rheumatoid arthritis; Placebo; Internal medicine; Leflunomide; Rheumatology; Sulfasalazine; Methotrexate; Janus kinase inhibitor; Tofacitinib; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001903291,0.001657864,0.003579838,0.0003783896,0.0004412495,0.00118032,0.000745523,0.002307812,0.005130235],"category_scores_gemma":[0.001853223,0.0006484585,0.002596243,0.0003913861,0.001346691,0.001335533,0.0004002143,0.00295756,0.0009532942],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006328162,"about_ca_system_score_gemma":0.000817359,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007074488,"about_ca_topic_score_gemma":0.001508235,"domain_scores_codex":[0.9994398,0.0002643522,0.00004051857,0.0001037919,0.00004779024,0.0001037374],"domain_scores_gemma":[0.9989744,0.000351918,0.0002454892,0.00007835283,0.0000664542,0.0002834302],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9876013,0.001375624,0.0005916377,0.0005441312,0.0008236074,0.00003992488,0.00003067567,0.0001743202,0.001190378,0.00006183669,0.000483491,0.007083036],"study_design_scores_gemma":[0.9559689,0.04073393,0.001699687,0.00003521192,0.0006067014,0.00005240905,0.00001795763,0.0002249645,0.0002097164,0.0001127161,0.0003230442,0.00001478664],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9846629,0.008939983,0.0005033769,0.0006924397,0.0005541016,0.001508989,0.00101576,0.0001005862,0.002021768],"genre_scores_gemma":[0.9906137,0.003048579,0.0006709491,0.0009990416,0.0004552391,0.001273645,0.001130759,0.00001795548,0.001790175],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005130235,"threshold_uncertainty_score":0.01716232,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02366137029739574,"score_gpt":0.3052305847661442,"score_spread":0.2815692144687485,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}